AlphaYou
Overview
8 funds hold it, insiders have been net selling, and 2 straight earnings beats.
Key stats
Sep 7- Open
- $275.13
- 52-wk high
- $281.07
- High
- $277.80
- 52-wk low
- $169.49
- Low
- $274.75
- Prev close
- $278.43
- Mkt cap
- $663.28B
- P/E
- 32.0x
- Volume
- 4.32M
- Fwd P/E
- 21.7x
- Beta
- 0.23
- Div yield
- 1.88%
- P/S
- 6.8x
- P/B
- 7.9x
- Profit margin
- +21.5%
- Op margin
- +29.2%
- ROE
- +25.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position, insiders have been net selling, and 1 fin-fluencer is discussing it.
What funds are doing
Earnings
Earnings came in 2.1% above what analysts expected.
Earnings per share
$2.84 expected
Revenue
No comparable estimate
FY2026 guidance
$100.80B to $101.40B
No comparable estimate
Reports Oct 13, 2026, in 36 days
EPS expected
$2.31 to $2.49
Revenue expected
4 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $23.99B | $24.56B | $24.06B | $25.31B |
| Cost of what it sold | $7.30B | $7.97B | $6.86B | $6.81B |
| Gross profit | $16.69B | $16.60B | $17.20B | $18.50B |
| What it spent | ||||
| Research and development | $3.67B | $4.25B | $3.53B | $3.65B |
| Sales and admin | $5.92B | $6.95B | $6.03B | $6.43B |
| Other operating costs | — | -$200.0M | $1.25B | $1.25B |
| Total operating expenses | $9.59B | $11.01B | $10.81B | $11.33B |
| What was left | ||||
| Operating profit | $7.10B | $5.59B | $6.39B | $7.17B |
| Interest on debt | $245.0M | $214.0M | $272.0M | $281.0M |
| Profit before tax | $7.49B | $4.97B | $5.99B | $6.75B |
| Tax | $2.34B | -$150.0M | $755.0M | $1.21B |
| Net profit | $5.15B | $5.12B | $5.24B | $5.53B |
| EBITDA | $9.29B | $7.19B | $8.27B | $8.99B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Was JNJ Stock Rally Actually Its Own?
Leans bullishSep 4Trailing rivals, AbbVie scores win with dual-acting myeloma drug
NeutralSep 4AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
NeutralSep 4J&J EVP Timothy Schmid sells $9.2m in company stock
Leans bearishSep 4Johnson & Johnson Is Boring Which Makes Its Dividend Nearly Perfect.
BullishSep 4Is Texas Instruments (TXN) Cheap After Rising Oil Prices And Treasury Yields Hit Semis?
BullishSep 3Is Johnson & Johnson Stock Priced For More Growth Than It Has Guided?
Leans bearishSep 3Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit
NeutralSep 3
Macro
20 macro signals shaping JNJ right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results